Age No Barrier to Preserved QoL, Functional Recovery After Surgery for CRC
(MedPage Today) -- Most older patients who had surgery for colorectal cancer (CRC) had functional recovery (FR) with preserved quality of life (QoL), a large prospective study showed. Three-fourths of patients had functional recovery 3-6 months... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 13, 2023 Category: Primary Care Source Type: news

The Key to Fighting Antimicrobial Resistance? Dollars, Experts Say
(MedPage Today) -- The U.S. cannot begin to tackle the problem of antimicrobial resistance without first changing the way antibiotics are reimbursed, experts argued during a Senate hearing on Tuesday. "Antibiotics ... are curative life-saving... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 12, 2023 Category: Primary Care Source Type: news

Social Isolation Tied to Brain Volume in Older Adults
(MedPage Today) -- Frequency of social contact was tied to brain volume in cognitively normal older adults, a cross-sectional study in Japan showed. Total brain volume was smaller in people who had the lowest frequency of social contact versus... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 12, 2023 Category: Primary Care Source Type: news

AKI Cleared of Worsening CKD Trajectory
(MedPage Today) -- Acute kidney injury (AKI) didn't predict worsening kidney function in people with chronic kidney disease (CKD), a prospective study showed. According to findings from the Chronic Renal Insufficiency Cohort (CRIC) study, CKD... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 11, 2023 Category: Primary Care Source Type: news

Imaging for Back and Joint Pain: Overuse Is an International Problem
(MedPage Today) -- Records in an Australian database indicated that primary care physicians very often order diagnostic imaging for patients with musculoskeletal pain shortly after first seeing them, despite evidence and guidelines that say these... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 7, 2023 Category: Primary Care Source Type: news

Survey Shows Primary Care Got a Pay Bump
(MedPage Today) -- Medical groups and healthcare organizations reported a 6.1% increase in primary care compensation from 2021 to 2022, compared with increases of 1.5% and 1.6% for medical and surgical specialties, respectively, according to survey... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 6, 2023 Category: Primary Care Source Type: news

Why Isn't Buprenorphine Available at All Pharmacies?
(MedPage Today) -- You're dealing with a life-threatening illness that has an effective treatment. The only problem is the medication is only available at about 60% of pharmacies. What now? This isn't a hypothetical for patients with opioid use... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 2, 2023 Category: Primary Care Source Type: news

Time to Incorporate Quality Measures Into Telemedicine
(MedPage Today) -- Although remote diagnosis and treatment of patients by means of telecommunication technology may seem like something new, that is not the case. Fun facts: The idea was discussed in an 1879 article in The Lancet (using the telephone... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 30, 2023 Category: Primary Care Source Type: news

CDC: 'Drastic' Rise in Tranq-Related Overdose Deaths
(MedPage Today) -- Drug overdose deaths with xylazine involvement have multiplied, with age-adjusted death rates 35 times higher in 2021 than in 2018, the CDC reported. The age-adjusted rate of drug overdose deaths involving the animal sedative... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 30, 2023 Category: Primary Care Source Type: news

Berry Eaters Beware: Hepatitis A May Be Lurking
(MedPage Today) -- *Patient's name has been changed. Late last year, the U.S. began to see a tiny flurry of hepatitis A virus [HAV] infections linked to frozen, organic strawberries grown on farms in Baja, Mexico. At the time of this writing... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 28, 2023 Category: Primary Care Source Type: news

Without Early Detection, Fighting Dementia Is an Uphill Battle
(MedPage Today) -- The FDA is expected to grant full approval soon to the Alzheimer's therapy lecanemab (Leqembi). When that happens, physicians and their patients will have to navigate the path to access and reimbursement, and wrestle with concerns... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 27, 2023 Category: Primary Care Source Type: news

Semaglutide Plus Cagrilintide Reduced Blood Sugar, Weight in T2D
(MedPage Today) -- SAN DIEGO -- Treatment with semaglutide 2.4 mg co-administered with the investigational long-acting amylin analogue cagrilintide (known together as CagriSema) led to improvements in glycemic control and reductions in body weight... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 27, 2023 Category: Primary Care Source Type: news

Two T1D Patients Achieve Insulin Independence After Stem Cell Transplants
(MedPage Today) -- SAN DIEGO -- Stem cell-derived islet cell therapy continued to show promise for the management of type 1 diabetes (T1D) with severe hypoglycemia, according to results from a small phase I/II clinical trial. All six Part A... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 27, 2023 Category: Primary Care Source Type: news

High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Loss
(MedPage Today) -- SAN DIEGO -- Once-daily oral semaglutide proved effective for weight loss in people with obesity, according to the phase III OASIS 1 trial. When added to lifestyle intervention over 68 weeks, patients taking 50 mg of oral... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 27, 2023 Category: Primary Care Source Type: news

Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial
(MedPage Today) -- SAN DIEGO -- An investigational triple-hormone receptor agonist yielded major weight loss in people with obesity, a phase II trial showed. By 24 weeks, patients on any of the four doses of once-weekly injectable retatrutide... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 26, 2023 Category: Primary Care Source Type: news